These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34374773)

  • 81. Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus-diphtheria vaccines in infancy.
    Korkmaz HA; Aydin A; Unal B
    Paediatr Int Child Health; 2014 Aug; 34(3):198-202. PubMed ID: 24621240
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults.
    Scott LJ
    Paediatr Drugs; 2011 Apr; 13(2):133-5. PubMed ID: 21351814
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
    Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
    J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impact of a pertussis epidemic on infant vaccination in Washington state.
    Wolf ER; Opel D; DeHart MP; Warren J; Rowhani-Rahbar A
    Pediatrics; 2014 Sep; 134(3):456-64. PubMed ID: 25136046
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life.
    Tozzi AE; Ravà L; Ciofi degli Atti ML; Salmaso S;
    Pediatrics; 2003 Nov; 112(5):1069-75. PubMed ID: 14595048
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
    Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines.
    Tozzi AE; Anemona A; Stefanelli P; Salmaso S; Ciofi degli Atti ML; Mastrantonio P; Giammanco A;
    Pediatrics; 2001 Feb; 107(2):E25. PubMed ID: 11158499
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study.
    Paireau J; Guillot S; Aït El Belghiti F; Matczak S; Trombert-Paolantoni S; Jacomo V; Taha MK; Salje H; Brisse S; Lévy-Bruhl D; Cauchemez S; Toubiana J
    Lancet Infect Dis; 2022 Feb; 22(2):265-273. PubMed ID: 34672963
    [TBL] [Abstract][Full Text] [Related]  

  • 91. California pertussis epidemic, 2010.
    Winter K; Harriman K; Zipprich J; Schechter R; Talarico J; Watt J; Chavez G
    J Pediatr; 2012 Dec; 161(6):1091-6. PubMed ID: 22819634
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region.
    Dolhain J; Janssens W; Sohn WY; Dindore V; Mukherjee P
    Expert Rev Vaccines; 2019 Sep; 18(9):921-933. PubMed ID: 31328999
    [No Abstract]   [Full Text] [Related]  

  • 93. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.
    Sala-Farré MR; Arias-Varela C; Recasens-Recasens A; Simó-Sanahuja M; Muñoz-Almagro C; Pérez-Jové J
    Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):27-31. PubMed ID: 24216286
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Waning Tdap Effectiveness in Adolescents.
    Klein NP; Bartlett J; Fireman B; Baxter R
    Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants.
    Winter K; Cherry JD; Harriman K
    Clin Infect Dis; 2017 Jan; 64(1):9-14. PubMed ID: 27624956
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Lack of association between acellular pertussis vaccine and seizures in early childhood.
    Huang WT; Gargiullo PM; Broder KR; Weintraub ES; Iskander JK; Klein NP; Baggs JM;
    Pediatrics; 2010 Aug; 126(2):263-9. PubMed ID: 20643726
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Predictors of age-appropriate receipt of DTaP dose 4.
    Strine TW; Luman ET; Okoro CA; McCauley MM; Barker LE
    Am J Prev Med; 2003 Jul; 25(1):45-9. PubMed ID: 12818309
    [TBL] [Abstract][Full Text] [Related]  

  • 98. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
    Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
    Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana.
    Afari EA; Kamiya Y; Nkrumah FK; Dunyo SK; Akpedonu P; Kamiya H; Fukai F
    Ann Trop Paediatr; 1996 Mar; 16(1):39-48. PubMed ID: 8787364
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index.
    Duszynski KM; Pratt NL; Lynch JW; Berry JG; Gold MS;
    Vaccine; 2019 Jan; 37(2):280-288. PubMed ID: 30503081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.